Tarec K. Elajami, MD, FACC

Assistant Professor of Medicine at NYMC School of Medicine/Mount Sinai Medical Center #echofirst #CVImaging #cvPrev #CardiovascularResearch 🇱🇧🇨🇦

[Tarec K. Elajami, MD, FACC @DrTcard]

Honored to share our editorial in the European Heart Journal, written alongside @LaylaAbushamat & the incredible @CBallantyneMD, discussing pre-clinical work by Alcover et al. https://t.co/rSlefm800k https://t.co/BzmllNGznF
#REDUCEIT #EPA #Cvprev #Resolvins #CardioTwitter #EHJ

[Priscilla Wessly @PWesslyMD]

Important and timely work exploring how inflammation + cardiometabolic dysfunction intersect in PAD. 🩸🦵
Excellent collaboration by @SahilGhay, @DrTcard ,@UjuetaFrancisco and team 👏
CTI may help uncover vascular risk that traditional markers alone can miss — especially in early/subclinical disease.

#CardioTwitter #PAD #Atherosclerosis #PreventiveCardiology

[Tarec K. Elajami, MD, FACC @DrTcard]

Proud of our team. We need to improve PAD prediction.

@UjuetaFrancisco @GLamasMD @ee412 @CGMihosDO @PWesslyMD

🌟 @SahilGhay @BaneetKaur
#PAD #CVprev #CardioX #CardioTwitter

[Sahil Ghay @SahilGhay]

🚨 New publication in Atherosclerosis Plus 🫀

Can a simple inflammatory-metabolic index help identify PAD risk?

In our analysis of U.S. adults, the C-reactive protein–triglyceride-glucose index (CTI) was independently associated with lower-extremity peripheral artery disease.

Key findings 👇
🔹 Each 1-unit ↑ in CTI = 47% higher adjusted odds of PAD
🔹 Highest CTI quartile = >2-fold higher odds vs lowest quartile
🔹 CTI was linked to both clinical PAD and borderline ABI
🔹 CTI outperformed TyG and improved PAD discrimination beyond metabolic risk alone

These findings suggest CTI may offer complementary insight into vascular risk and early/subclinical PAD. 🚶‍♂️🩸

Grateful to our amazing team and collaborators!

https://t.co/H5lWAhu3cj

[Sahil Ghay @SahilGhay]

🚨 New publication in Atherosclerosis Plus 🫀

Can a simple inflammatory-metabolic index help identify PAD risk?

In our analysis of U.S. adults, the C-reactive protein–triglyceride-glucose index (CTI) was independently associated with lower-extremity peripheral artery disease.

Key findings 👇
🔹 Each 1-unit ↑ in CTI = 47% higher adjusted odds of PAD
🔹 Highest CTI quartile = >2-fold higher odds vs lowest quartile
🔹 CTI was linked to both clinical PAD and borderline ABI
🔹 CTI outperformed TyG and improved PAD discrimination beyond metabolic risk alone

These findings suggest CTI may offer complementary insight into vascular risk and early/subclinical PAD. 🚶‍♂️🩸

Grateful to our amazing team and collaborators!

https://t.co/H5lWAhu3cj

[Sahil Ghay @SahilGhay]

Amazing editorial highlighting how EPA-derived pro-resolving mediators may help explain EPA-EE’s cardioprotection beyond triglyceride lowering, with potential roles in inflammation resolution and plaque stabilization!

[Tarec K. Elajami, MD, FACC @DrTcard]

@DrAlfaddagh @amrabbasmd @madonatelle

Our new paper on disparities in TAVR outcomes! Important gaps remain. We need to do better!

#Cardiotwitter #disparity #CVoutcomes

[Sahil Ghay @SahilGhay]

🚨 New paper out in Cardiovascular Revascularization Medicine 🚨

We analyzed 469,175 urban TAVR hospitalizations from 2016-2022.

The signal was clear:

🫀 Black and Hispanic patients had higher cardiometabolic burden
⚠️ Hispanic patients had higher mortality, MACE, AKI/dialysis, mechanical ventilation, transfusion, and cost
⚠️ Black patients had higher MACE, AKI, prolonged LOS, and CPR
✅ Stroke outcomes were similar across groups

The takeaway: TAVR has advanced dramatically, but equity in outcomes still needs to catch up.

Proud of our team and grateful to everyone involved.

https://t.co/1W52C1fLI3

#TAVR #Cardiology #HealthEquity #StructuralHeart #MedTwitter

[Tarec K. Elajami, MD, FACC @DrTcard]

@CBallantyneMD @nationallipid @BCMHeart @vijay_nambi @LaylaAbushamat @virani_md Congratulations @CBallantyneMD!

[Christie Ballantyne @CBallantyneMD]

This is a tremendous honor. Virgil Brown has been an outstanding researcher, clinician, educator and leader @nationallipid This award is a tribute to my mentors, trainees, colleagues and collaborators @BCMHeart @vijay_nambi @LaylaAbushamat @virani_md

[Tarec K. Elajami, MD, FACC @DrTcard]

@danielaurinaj @CBallantyneMD @ACCinTouch @LaylaAbushamat

[Daniela Urina Jassir, MD, FACC @danielaurinaj]

The best thing about ACC is not only connecting with friends but with family! 💚💜💛⚜️ 🎷 @CBallantyneMD @DrTcard @ACCinTouch #ACC2026 #cvprev #cardiovascularResearch

[Tarec K. Elajami, MD, FACC @DrTcard]

#ACC2026 #metainflammation

[Daniela Urina Jassir, MD, FACC @danielaurinaj]

@ACCinTouch Our stellar residents presenting at #ACC26. The future of cardiology 💜💛💚⚜️🌟 @SahilGhay @DrTcard @MountSinaiMiami

[Daniela Urina Jassir, MD, FACC @danielaurinaj]

@ACCinTouch Our stellar residents presenting at #ACC26. The future of cardiology 💜💛💚⚜️🌟 @SahilGhay @DrTcard @MountSinaiMiami

[Tarec K. Elajami, MD, FACC @DrTcard]

@PWesslyMD @SahilGhay @LaylaAbushamat @ElajamiMohamad @HishamBahmad Thank you @PWesslyMD! See you at #ACC2026

[Tarec K. Elajami, MD, FACC @DrTcard]

Great job @SahilGhay!
#CVPrevention
@LaylaAbushamat @ElajamiMohamad @HishamBahmad

[Sahil Ghay @SahilGhay]

New data from 10,421 patients with metabolic syndrome: the C-reactive protein-triglyceride-glucose index (CTI) outperformed 23 cardiometabolic markers — including TyG, CRP, NLR, and non-HDL-C — as a predictor of CV mortality.

Patients in the highest CTI quartile had a 60% higher risk of CV death.

Integrating inflammation + metabolic stress into a single index may be the key to better risk stratification in MetS.
📄 Journal of Clinical Lipidology (2026)
#Cardiology #MetabolicSyndrome #CVDRisk #Inflammation #PreventiveCardiology

https://t.co/CAWw1R35q7

[Priscilla Wessly @PWesslyMD]

❓What is the radiation reality for Interventional Echocardiographers (IEs) in the U.S.?
🚨 Our newly published U.S. data reveal radiation safety gaps:
🔻 75% report inadequate cath lab protection
🔻 18% use no dosimeter at all
🔻 80% are unaware of their annual radiation dose
🔻 71% report reproductive health concerns
It's time for IE-specific safety standards. 🔗https://t.co/0sen6WALlB
#RoadToZero @renujain19 @nishath_quader @EGarciaSayan @SLittleMD @OKhaliqueMD @NadeenFaza @crfshj

[Bashaer Gheyath MD FACC 🫀👩🏻‍⚕️ @Bgheyath]

Can’t believe it’s been since ACC23 ! Loved connecting with some of my US ACC peeps! Can’t wait for the next one ✨💕#ACCMidEast

[Tarec K. Elajami, MD, FACC @DrTcard]

@__Arjun_reddy__ @Bgheyath @ElajamiMohamad @danielaurinaj Thank you for your question Arjun. We used only NHANES for this analysis and showed a significant association. More validation is required across other cohorts including ones in the Middle East!

[American College of Cardiology @ACCinTouch]

Don’t forget to check out the poster presentations at #ACCMidEast!

#ACCIntl

[Tarec K. Elajami, MD, FACC @DrTcard]

@LaylaAbushamat @CGMihosDO @ee412 @PWesslyMD @ElajamiMohamad @danielaurinaj

[American College of Cardiology @ACCinTouch]

Don’t forget to check out the poster presentations at #ACCMidEast!

#ACCIntl

[Bashaer Gheyath MD FACC 🫀👩🏻‍⚕️ @Bgheyath]

Don’t miss out! 🔬🫀CardioTwitter! “At #ACCMidEast presented how the Triglyceride-Glucose Index predicts CV mortality in metabolic syndrome. Important insights into precision risk stratification in diverse populations. 🔬❤️ the team is here from Miami ! 🌴@ElajamiMohamad